跳至主要内容
临床试验/ISRCTN44359668
ISRCTN44359668已完成未知

Medical treatment of Meniere's disease with betahistine: a placebo-controlled, dose-finding study

niversity Hospital Grosshadern (Klinikum Grosshadern) (Germany) - Department of Neurology0 个研究点目标入组 186 人开始时间: 2007年9月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
186

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Definite Meniere's disease according to the American Academy of Ophthalmology and Otolaryngology, Head and Neck Surgery:
  • 1.1. Two or more attacks of vertigo, each lasting more than 20 minutes
  • 1.2. Audiometrically documented hearing loss in at least one examination
  • 1.3. Tinnitus or aural fullness in the affected ear
  • 1.4. Other causes excluded
  • 2. At least two attacks of Meniere's disease per month for at least three subsequent months
  • 3. Aged 18 to 80 years
  • 4. Written informed consent to all protocol-specified procedures

排除标准

  • 1. Other vestibular disorders such as vestibular migraine or phobic postural vertigo
  • 2. Contraindications for treatment with betahistine-dihydrochloride, such as:
  • 2.1. Asthma bronchiale
  • 2.2. Pheochromacytoma
  • 2.3. Pregnancy or breast-feeding
  • 2.4. Severe dysfunction of kidneys or liver
  • 2.5. Ulcer of the stomach or duodenum
  • 2.6. Tumours
  • 2.7. Severe coronary heart disease
  • 2.8. Treatment with other antihistamines

研究者

发起方
niversity Hospital Grosshadern (Klinikum Grosshadern) (Germany) - Department of Neurology

相似试验